This composite pathway integrated multiple oncogenic mechanisms and encompassed several classical tumour related signalling pathways, inclding PI3K-AktPI3K-Akt signaling pathway, Ras signaling pathway, HIF-1 signaling pathway, and EGFR tyrosine kinase inhibitor resistance. The gene discussed is PIK3CB; the disease is neoplasm.